三生制药(01530)拟于2026年8月20日召开董事会审议中期业绩及股息分派

公告速递
Aug 07

三生制药(01530)7日发布董事会会议通告称,公司董事会将于2026年8月20日(星期四)召开会议,审议并批准刊发集团截至2026年6月30日止六个月的未经审核中期业绩,并考虑派发中期股息(如有)。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10